Seeking more efficient drug development, pharmaceutical giants and startups are encouraging AI fluency and in some cases ...

Artificial intelligence continues stirring things up in chemistry. To wit: Y Combinator-backed Cambridge, U.K.-based ...

Eli Lilly’s experimental drug, lepodisiran, reduces lipoprotein(a) (Lp[a]) levels by an average of 93.9 per cent in a ...

has the promise to lead to new paradigms and cost savings in drug development, all of which would strengthen the industry and its ability to develop innovative and much-needed therapies for ...

“This is a really exciting new area that has tremendous potential to assist drug discovery and development,” says ... but we also need to deeply understand how the models work in a clinical ...

In this transformative environment, a new drug development paradigm is needed if healthcare is to remain both effective and affordable. The future of drug development and the central role that ...

Scientists say a new AI method for looking at cells could speed up drug development by six years ... “Patients with cancer need new treatment options as quickly as possible, so speeding up ...

In an article published in the Journal of the American Chemical Society, a University of California, Irvine-led team ...

Every few days, doctors needed to drain liters ... money to be made developing a new drug for a small number of patients, said Christine Colvis, who heads drug development partnership programs ...

already resistant to our most effective antifungal drugs, which are also five times more likely to acquire resistance to desperately needed new treatments in development. The study—led by two ...